CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/healthcare

healthcare organization

Dana-Farber Brigham Cancer Center

US

OPENALEX: I4210161994↗ROR: 05rgrbr06↗

People

Connected researchers

Kaylie DecosmoORCID 0000-0002-3752-011X Michèle MoreauORCID 0000-0002-6881-6300 Noella BihExact authorship link Peter R. ChaiORCID 0000-0003-0955-4117 Sayeda Yasmin‐KarimExact authorship link Udoka IbehORCID 0000-0003-1120-5389 Wilfred NgwaORCID 0000-0001-8317-6850

Public evidence

2 connected articles

Corrigendum: Flavonoid Derivative of <i>Cannabis</i> Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer.2020 · PubMed Central Open Access Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer.2019 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: OpenAlex.

Dana-Farber Brigham Cancer Center - Medical Cannabis Research Engine